Introduction: The predictive role of 18F-FDG-PET/CT (FP) in neuroendocrine tumours is debated.
Aim(s): To evaluate the correlation between FP and response to chemotherapy (CHT) and everolimus (E) for pancreatic NETs (PanNETs).
Materials and methods: Baseline and post-treatment imaging studies (contrast enhanced CT/MRI and FP) of 31 patients (P) treated for advanced, G1-2 PanNETs were retrospectively reviewed. A per lesion analysis was conducted, separately for each treatment arm (CHT and E), selecting up to 6 lesions (L) for each P. Baseline FP results (positive if SUV max > 3.5) and RECIST1.1 disease control rate (DCR) and objective response rate (ORR) were analyzed for possible correlations.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: MD Silvia Ortolani
, Cingarlini S
, Citton E
, Crosara S
, De Robertis R
, Grego E
, Vallerio P
, D'Onofrio M
, Butturini G
, Landoni L
, Capelli P
, Zuffante M
, Ferdeghini M
, Salgarello M
, Tortora G
To read results and conclusion, please login ...
Further abstracts you may be interested in